Related Experiment Video

Updated: Jun 10, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Invasive fungal disease in patients treated for newly diagnosed acute leukemia

Sarah P Hammond1, Francisco M Marty, Julie M Bryar

  • 1Division of Infectious Diseases, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. shammond2@partners.org

American Journal of Hematology
|July 24, 2010
PubMed

Insights

Invasive fungal disease (IFD) is a serious risk for acute leukemia (AL) patients. Persistent leukemia and prolonged neutropenia significantly increase the likelihood of developing IFD during treatment.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Oncology

Background:

  • Invasive fungal disease (IFD) presents a significant challenge in acute leukemia (AL) treatment, contributing to morbidity and mortality.
  • Current antifungal prophylaxis strategies carry substantial toxicities and economic burdens.

Purpose of the Study:

  • To investigate the incidence and identify risk factors for IFD in patients undergoing treatment for newly diagnosed AL.
  • To analyze IFD development within the first 100 days post-diagnosis.

Main Methods:

  • Retrospective study of 231 patients diagnosed with and treated for AL between January 1, 2004, and July 1, 2006.
  • Follow-up concluded January 1, 2007, with data analysis focusing on IFD incidence and associated risk factors.
  • Time-dependent Cox regression model utilized to assess the impact of neutropenia duration on IFD risk.

Main Results:

  • Overall, 13.4% of patients developed IFD, with 10.4% occurring within the first 100 days of AL diagnosis.
  • Patients with persistent leukemia post-induction chemotherapy had a higher incidence of IFD (21.5% vs. 10.1%, P=0.03).
  • Each additional day of neutropenia within the first 100 days increased IFD risk by a hazard ratio of 4.85.

Conclusions:

  • Persistent leukemia and prolonged neutropenia are critical risk factors for IFD development in AL patients.
  • Early identification and management of neutropenia are crucial for mitigating IFD risk.
  • Further research into targeted prophylactic strategies considering individual risk profiles is warranted.

More Related Videos

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...